Found: 6
Select item for more details and to access through your institution.
COMPLEMENT SYSTEM AND RHEUMATOID ARTHRITIS: RELATIONSHIPS WITH AUTOANTIBODIES, SEROLOGICAL, CLINICAL FEATURES, AND ANTI-TNF TREATMENT.
- Published in:
- International Journal of Immunopathology & Pharmacology, 2011, v. 24, n. 2, p. 357, doi. 10.1177/039463201102400209
- By:
- Publication type:
- Article
INHIBITION OF THE COMPLEMENT SYSTEM BY GLUTATHIONE: MOLECULAR MECHANISMS AND POTENTIAL THERAPEUTIC IMPLICATIONS.
- Published in:
- International Journal of Immunopathology & Pharmacology, 2011, v. 24, n. 1, p. 63, doi. 10.1177/039463201102400108
- By:
- Publication type:
- Article
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment.
- Published in:
- Clinical & Experimental Immunology, 2014, v. 177, n. 1, p. 234, doi. 10.1111/cei.12335
- By:
- Publication type:
- Article
An open randomized active-controlled clinical trial with low-dose SKA cytokines versus DMARDs evaluating low disease activity maintenance in patients with rheumatoid arthritis.
- Published in:
- Drug Design, Development & Therapy, 2017, v. 11, p. 985, doi. 10.2147/DDDT.S118298
- By:
- Publication type:
- Article
Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article